With the help of the experienced BevCanna team, one of California’s leading vape brands, Bloom, is set to hit shelves in Canada. Launched by Capna Intellectual in 2015, Bloom has been a California fan favorite and staple brand for the past five years.
Canada marks the sixth territory and first country out of the United States where Bloom is sold. With a population rivaling California, Canada will be Bloom’s second biggest market by a landslide. “We’ve proven the ability to scale Bloom in competitive markets throughout the United States,” says Capna Intellectual Chief Revenue Officer Casey Ly, “We are well equipped to deliver the consistent quality Canadian consumers expect from a brand of our caliber.”
Canada marks an important step for both Bloom and parent Capna Intellectual, a California-based cannabis company that has shifted its focus from vertical integration to brand expansion over the last year. Canada will be the first territory launched after Bloom’s transition out of its flagship production and distribution facility in Greenfield, California. “We are confident we have found the right partners to supply Bloom in California. The shift away from owning our own supply chain in California allows us to invest in product development, marketing, and most importantly; expansion,” noted Capna Intellectual Chief Operating Officer Amish Patel.
Capna Intellectual will be the exclusive vape partner to BevCanna Enterprises (CSE: BEV) in Canada. The Capna Intellectual team plans to work hand in hand with BevCanna to ensure the proper commercialization of Bloom. “Consumers are looking for trusted brands to explore their experiences with cannabis. We [Bloom] allow consumers to enjoy amazing cannabis strains in accessible formats,” says Capna Intellectual CEO Vitaly Mekk, “BevCanna shares our vision, and they have the consumer-packaged goods experience to bring Bloom to Canada.”
In addition to the production of Bloom’s vape offerings, BevCanna offers the potential for Bloom to launch flower and beverage products as well. Bloom has launched a pre-roll line in Q1 in California and is exploring launching consumable products. “It was important to find a like-minded partner like BevCanna who recognizes the importance of product innovation,” says Mehdi Sinaki, Capna Intellectual General Counsel. Bloom products will be sold under the moniker “Cali-Bloom” to honor the Californian roots of the brand’s identity. Capna plans to launch Bloom’s full oil-based product line, including prefilled vaporizer cartridges and pods, oil applicators and all-in-one disposables.
About Capna Intellectual
Based in Los Angeles, Capna Intellectual specializes in developing consumer packaged goods for the cannabis market. Capna Intellectual is best known for creating the Bloom brand, which is now sold in five States: California, Nevada, Washington, New Mexico, and Oklahoma. Since 2015, Capna Intellectual’s team has driven product innovation while implementing the strictest operating procedures to ensure compliance, consistency, and quality.
For media inquiries or interviews, please contact:
Cristina Burlacu, Capna Intellectual
For investor inquiries, please contact:
Casey Ly, Capna Intellectual
About BevCanna Enterprises Inc.
BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 292-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles per annum.
For media inquiries or interviews, please contact:
Wynn Theriault, Thirty Dash Communications Inc.
This press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE Capna Intellectual
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/